6533b828fe1ef96bd1288e3b

RESEARCH PRODUCT

Posaconazole (POS) vs fluconazole (FLU) for prophylaxis of invasive fungal infections (IFIs) in allogeneic hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host disease (GVHD): A multicenter trial

Hernando PatinoSimon DurrantJeffrey H. LiptonAmelia LangstonDavid H. VesoleAndrew J. UllmannLisa D. Pedicone

subject

TransplantationPosaconazolebusiness.industryHematologyrespiratory systemmedicine.diseaseGraft-versus-host diseaseMulticenter trialImmunologymedicineAllogeneic hematopoietic stem cell transplantbusinessFluconazolemedicine.drughttps://doi.org/10.1016/j.bbmt.2005.11.412